Compare propofol and midazolam apnoea doses separately and then combined
propofol induction dose apnoea respiratory depression
midazolam dose apnoea respiratory depression sedation
propofol midazolam combined synergistic sedation apnoea interaction
| Parameter | Detail |
|---|---|
| Mechanism | GABA-A potentiation + direct central respiratory centre depression |
| Induction dose | 1.5–2.5 mg/kg IV (healthy adult); 1.0–1.5 mg/kg if premedicated |
| Apnoea dose | Apnoea occurs in ~25–30% of patients at standard induction doses (1.5–2.5 mg/kg); nearly universal at ≥2.5 mg/kg bolus |
| Apnoea onset | Within 30–60 seconds of bolus injection |
| Apnoea duration | Typically 30–90 seconds after a single induction bolus; longer with infusions |
| Reduced-dose populations | Elderly / ASA III–IV: 1.0–1.5 mg/kg; consider 0.5 mg/kg incremental dosing |
| Key feature | Steep dose-response curve; small dose increments cause disproportionate respiratory depression |
Propofol's apnoea risk is substantially higher than equipotent doses of midazolam alone. Even sub-induction doses (0.5–1.0 mg/kg) cause significant respiratory depression when given rapidly.
| Parameter | Detail |
|---|---|
| Mechanism | GABA-A potentiation (benzodiazepine site); less direct brainstem respiratory depression than propofol |
| Sedation dose | 0.02–0.05 mg/kg IV (procedural sedation) |
| Induction dose | 0.1–0.2 mg/kg IV (used alone; rarely used as sole induction agent) |
| Apnoea dose (alone) | Apnoea is uncommon at normal sedation doses; risk increases significantly above 0.1 mg/kg, particularly with rapid injection |
| Apnoea onset | Slower than propofol — peak effect at 2–3 minutes |
| Apnoea duration | Longer duration of effect (half-life 1.5–2.5 hours); apnoea if it occurs tends to last longer |
| Ceiling effect | Has a relative ceiling on respiratory depression compared to propofol; however, this ceiling disappears with co-administration of opioids or propofol |
| Reversible with | Flumazenil (0.2 mg IV, repeat to 1 mg max) |
Midazolam alone, at typical sedation doses (0.02–0.05 mg/kg), rarely causes frank apnoea in healthy adults. The risk rises with doses >0.1 mg/kg, rapid injection, and in elderly or compromised patients.
| Parameter | Detail |
|---|---|
| Pharmacodynamic interaction | Synergistic (supra-additive): both act at GABA-A but at different binding sites, producing greater-than-additive CNS and respiratory depression |
| Dose reduction required | Propofol induction dose should be reduced by ~30–50% when preceded by midazolam premedication |
| Typical combined regime | Midazolam 1–2 mg IV (premedication) → wait 2–3 min → Propofol 0.5–1.0 mg/kg titrated to effect |
| Apnoea risk | Markedly increased; apnoea at doses of propofol (0.5–1.0 mg/kg) that would not reliably cause apnoea alone |
| Time course | Midazolam premedication shifts the propofol dose-response curve leftward — a lower propofol dose achieves the same sedation depth and apnoea |
| Clinical utility | Reduced total drug dose, smoother induction, but mandates airway preparedness |
| Reversibility | Propofol component not reversible; midazolam component reversible with flumazenil — partial reversal only |
| Feature | Propofol alone | Midazolam alone | Combined |
|---|---|---|---|
| Apnoea dose (healthy adult) | ~1.5–2.5 mg/kg IV | Uncommon at sedation doses; risk at >0.1 mg/kg | Propofol ~0.5–1.0 mg/kg with midazolam 1–2 mg pre-dose |
| Onset of apnoea | 30–60 seconds | 2–3 minutes (if occurs) | 30–90 seconds |
| Duration of apnoea | Short (30–90 sec) | Longer if occurs | Prolonged; more variable |
| Dose-response | Steep; predictable | Gradual; relative ceiling | Steep; supra-additive |
| Reversibility | No antidote | Flumazenil | Partial (flumazenil for midazolam only) |
| Risk in elderly | High; halve the dose | Moderate; use 0.01–0.02 mg/kg | Very high; use smallest possible doses with slow titration |
| Airway management | Mandatory preparation | Standby at sedation doses | Mandatory preparation |
typical combination doses for colonoscopy and gastroscopy
propofol midazolam sedation dosing colonoscopy endoscopy
conscious sedation gastroscopy upper endoscopy midazolam fentanyl dose protocol
| Drug | Dose | Timing |
|---|---|---|
| Fentanyl | 50–100 mcg IV | Give first, wait 2–3 min |
| Midazolam | 1–2 mg IV | Give after fentanyl, wait 2 min |
| Propofol | 40–60 mg IV bolus to induce, then 10–20 mg increments every 60–90 sec to maintain | Titrate to MOAA/S score 3–4 |
| Total propofol (typical) | 100–300 mg for a standard 20–30 min procedure | Less in elderly/frail |
| Drug | Dose | Timing |
|---|---|---|
| Fentanyl | 25–50 mcg IV (often omitted for routine gastroscopy) | If used, give first |
| Midazolam | 1–2 mg IV | Give 2 min before propofol |
| Propofol | 20–40 mg IV bolus to induce, then 10 mg increments as needed | Titrate carefully |
| Total propofol (typical) | 50–150 mg for a standard 5–15 min procedure | Much lower than colonoscopy |
| Population | Modification |
|---|---|
| Elderly (>70 years) | Reduce all doses by 30–50%; propofol 10–20 mg induction bolus, 5–10 mg increments; midazolam 0.5–1 mg |
| ASA III–IV | Similar reductions; consider anaesthetist-led sedation |
| Obese (BMI >35) | Dose on lean body weight for propofol; standard midazolam dose |
| Chronic benzodiazepine use | Midazolam less effective; may need higher propofol doses |
| Chronic opioid use | Fentanyl less effective; titrate carefully |
| Liver disease / cirrhosis | Midazolam half-life markedly prolonged; reduce dose significantly or avoid |